p,p'-Sulfonyldianiline-N,N'-digalactoside

CAS 1329-37-9 MFCD01329379

化学结构图

1329-37-9
SMILES: O=S(=O)(c1ccc(NC2OC(CO)C(O)C(O)C2O)cc1)c1ccc(NC2OC(CO)C(O)C(O)C2O)cc1

化学属性

Mol. Weight572.64
Mol. FormulaC24H32N2O12S

别名和识别编码

Chemical NameGalactosylamine, N,N'-(sulfonyldi-p-phenylene)bis-
Synonym G.A.P.S. Galactosylamine, N,N'-(sulfonyldi-4,1-phenylene)bis- Reconan N,N'-(Sulfonyldi-4,1-phenylene)bis(galactosylamine) N,N'-(Sulfonyldi-p-phenylene)bis-galactosylamine Coccicid p,p'-Sulfonyldianiline-N,N'-digalactoside Solufone Eupatin II Tibatin Digalactoside de la 4,4'-diamino-diphenyl-sulfone
CAS Number1329-37-9
InChIKeyWXCZDFLSCLWVSR-FHVCQGAUSA-N
PubChem Substance ID121439
InChIInChI=1S/C24H32N2O12S/c27-9-15-17(29)19(31)21(33)23(37-15)25-11-1-5-13(6-2-11)39(35,36)14-7-3-12(4-8-14)26-24-22(34)20(32)18(30)16(10-28)38-24/h1-8,15-34H,9-10H2/t15-,16-,17+,18+,19+,20+,21-,22-,23?,24?/m1/s1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

安全信息

RTECSLW5920000 
TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 20 gm/kg
TOXIC EFFECTS :
   Peripheral Nerve and Sensation - flaccid paralysis without anesthesia
   (usually neuromuscular blockage)
   Behavioral - convulsions or effect on seizure threshold
   Lungs, Thorax, or Respiration - other changes
REFERENCE :
   AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
   Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium)  V.4-   
   1898-  Volume(issue)/page/year: 91,260,1952

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 10 gm/kg
TOXIC EFFECTS :
   Peripheral Nerve and Sensation - flaccid paralysis without anesthesia
   (usually neuromuscular blockage)
   Behavioral - convulsions or effect on seizure threshold
   Biochemical - Metabolism (Intermediary) - effect on inflammation or
   mediation of inflammation
REFERENCE :
   AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
   Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium)  V.4-   
   1898-  Volume(issue)/page/year: 91,260,1952

系列性分类

相关产品推荐